 Immunocytochemical detection kappa lambda light chain region subgroups human B-cell malignancies sensitive immunoperoxidase method specific anti-light chain antisera light chain variable region VL nature cytoplasmic cell surface Ig human monoclonal plasma cells lymphocytes immunocytochemical characterization cIg sIg antisera specific kappa light chain kappa subgroups kappa kappa II kappa III kappa IV lambda light chain lambda subgroups lambda II/V IV lambda VI cytospin preparations bone marrow- peripheral blood- lymph node-derived cells patients multiple myeloma amyloidosis AL Waldenstrom macroglobulinemia low- mid- high-grade B-cell malignancies kappa subgroup cIg sIg deparaffinization enzyme treatment formalin-fixed paraffin-embedded specimens patients monoclonal serum urinary Igs complete concordance VL subgroup secreted Ig cIg sIg percentage distribution kappa subgroups sIg cells patients chronic lymphocytic leukemia CLL cytomorphologic types B-cell malignancies kappa- lambda-type Bence Jones proteins patients multiple myeloma amyloidosis AL Waldenstrom macroglobulinemia contrast plasma cell lymphocytoid plasma cell diseases relative predominance certain VL subgroups ie kappa IV III lambda IV absence amyloid-associated lambda VI subgroup CLL diseases immunocytochemical techniques possible rapid B-cell monoclonality evidence selective expression certain VL genes human B-cell neoplasia